title: Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia.
abstract: We sought to profile the epidemiological implication of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection from South and Southeast Asia by reviewing original studies reporting prevalence of HIV-HCV co-infection and their risk factors. Thirteen papers cited in the PubMed database and published in 2012 and 2013 were reviewed. The overall HCV co-infection prevalence ranged broadly from 1.2 % to 98.5 % among HIV-positive people in South and Southeast Asia. Among HCV seropositive blood donors in Nepal, 5.75 % had HIV co-infection. Injecting drug use (IDU) was one of the key risk factors of co-infection, with HCV infection reaching 89.8 % and 98.5 % among HIV-positive injecting drug users in Vietnam. The most recent data from South and Southeast Asia suggest the urgency of implementation of comprehensive prevention and control strategies of HIV-HCV co-infection.
authors.affiliation: National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, People's Republic of China, yeshaodong@chinaaids.cn.
authors.forename: Shaodong
authors.initials: S
authors.lastname: Ye
authors.forename: Lin
authors.initials: L
authors.lastname: Pang
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Wang
authors.forename: Zhongfu
authors.initials: Z
authors.lastname: Liu
mesh_terms: D001210:Asia, Southeastern / Q000453:epidemiology; D060085:Coinfection / Q000453:epidemiology* / Q000517:prevention & control; D015897:Comorbidity; D055030:Drug Users / Q000706:statistics & numerical data*; D014943:Global Health / Q000639:trends*; D015658:HIV Infections / Q000453:epidemiology* / Q000517:prevention & control; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D015995:Prevalence; D012307:Risk Factors